![](https://www.msomics.com/wp-content/uploads/2022/10/MergerLong.png)
WITH THE ACQUISITION OF MS-OMICS CLINICAL MICROBIOMICS BECOMES LEADING MULTI-OMICS PROVIDER FOR THE MICROBIOME FIELD
Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field. Copenhagen, October 17, 2022 –